key: cord-0969490-9olsm04u
authors: Ilhan, Bayazit; Cokal, Burcu G; Mungan, Yusuf
title: Response to comment on: Intracranial hypertension and visual loss following COVID-19: A case report
date: 2021-08-03
journal: Indian J Ophthalmol
DOI: 10.4103/ijo.ijo_1748_21
sha: 22e55780c702e0d14aebc10a5ce2a9ac1fae2e43
doc_id: 969490
cord_uid: 9olsm04u

nan

Dear Editor, We thank author(s) of the letter to the editor on our article "Intracranial hypertension and visual loss following COVID-19: a case report." [1, 2] The letter points out possible association between vitamin B12 deficiency and intracranial hypertension (IHT), which is a good discussion.

Vitamin B12 deficiency has been reported in patients with IHT in various case reports. Possible relation and mechanism are not ascertained yet. Vitamin B12 deficiency has been related to many clinical manifestations including the central nervous system; however, IHT is not a prominent one among them. [3] A possible mechanism has been discussed as venous stasis due to hypercoagulability, and some cases had cerebral venous sinus thrombosis related to that, [4] which was not present in our case. A possible association of IHT with various hypercoagulation disorders has been studied, but vitamin B12 deficiency was not among them. [5] We started acetazolamide treatment together with vitamin B12 and recommended to lose weight. Resolution of papilledema and improvement in visual field could be related to acetazolamide, which is considered as mainstay therapy.

The prominent risk factors for IHT in our patient were obesity, gender, and age. It is not possible to declare a cause and effect relationship with one case, but the important discussion is that COVID-19 could be a precipitating factor for IHT in this high-risk group, and when we search the literature, our patient is the first case discussed on this ground. Even if we discuss vitamin B12 deficiency as another risk factor in this patient, we should keep in mind this possible role of COVID-19 with the mechanisms discussed in our article. So, we think it is not possible to say "association between COVID-19 and IHT seems more coincidental in this case." It is necessary to study further on this topic to be aware of the condition and prevent severe morbidity.

Nil.

There are no conflicts of interest.

Intracranial hypertension and visual loss following COVID-19: A case report

Comment on: Intracranial hypertension and visual loss following COVID-19: A case report

Vitamin B12 deficiency: Recognition and management

A pediatric patient with recurrent pseudotumor cerebri and vitamin B12 deficiency

Benign intracranial hypertension associated to blood coagulation derangements